Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Delayed Quote USD

West Pharmaceutical Services, Inc. (WST)

211.29
+1.03
+(0.49%)
At close: May 2 at 4:00:02 PM EDT
211.29
0.00
(0.00%)
After hours: May 2 at 5:05:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Eric M. Green Non-Independent Chair of the Board, President & CEO 1.59M 54.24M 1970
Mr. Bernard J. Birkett Senior VP & CFO 887.33k -- 1969
Ms. Kimberly Banks MacKay Senior VP, General Counsel & Company Secretary 583.71k -- 1966
Ms. Annette F. Favorite Chief Human Resources Officer & Senior VP 545.78k -- 1965
Mr. Chad R. Winters VP of Finance & Chief Accounting Officer -- -- 1980
Mr. John P. Sweeney C.F.A. Head of Investor Relations -- -- --
Michele Polinsky Vice President of Global Communications -- -- --
Mr. Rudy Poussot Senior VP of Strategy & Corporate Development -- -- --
Ms. Kathy DePadua Senior VP and Chief Quality & Regulatory Officer -- -- --
Ms. Aileen Ruff-Patry President of Contract Manufacturing -- -- --

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341-1147
United States
610 594 2900 https://www.westpharma.com
Sector: 
Healthcare
Full Time Employees: 
10,600

Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Corporate Governance

West Pharmaceutical Services, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 6. The pillar scores are Audit: 7; Board: 9; Shareholder Rights: 4; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 23, 2025 at 12:30 PM UTC - July 28, 2025 at 12:30 PM UTC

West Pharmaceutical Services, Inc. Earnings Date

July 30, 2025 at 12:00 AM UTC

Ex-Dividend Date

August 6, 2025 at 12:00 AM UTC

Dividend Date

Recent Events

April 24, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 14, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 21, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 18, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 24, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 23, 2024 at 12:00 AM UTC

S-8 POS: Offering Registrations

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.